Satheesha Hanavadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Satheesha Hanavadi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Robert E. Mansel
Wales College of Medicine, Cardiff University
2 shared publicationsDibyesh Banerjee
1 shared publicationGareth Watkins
Wales College of Medicine, Cardiff University
1 shared publicationI.J. Monypenny
1 shared publicationIan J. Monypenny
1 shared publicationR.E. Mansel
1 shared publication
Latest Publications
- 14 April 2006
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 13 (6) , 802-808
Expression of Interleukin 11 and Its Receptor and Their Prognostic Value in Human Breast Cancer
Recent experimental evidence has shown a potential role of interleukin (IL)-11 and its receptor in breast cancer development and progression. However, there is little clinical information to support this hypothesis. We examined the expression of IL-11 and its receptor in primary breast cancer tissue samples and correlated their level of expression with the clinical outcome. Primary breast cancer samples (n=109) and matched background tissue obtained from patients in the cohort (n=33) were processed for frozen section and RNA extraction. Frozen sections from matched tissues were immunostained with IL-11 and IL-11 receptor antibodies. Staining intensity was analyzed by computer image analysis. RNA was reverse-transcribed and quantified before analysis by quantitative polymerase chain reaction. Results were expressed as the number of transcripts (standardized by beta-actin). The data were compared with the clinical outcome of the disease. The intensity of staining for both IL-11 and the IL-11 receptor was distinctly high in tumor samples (P<.01). The transcript level of IL-11 was significantly higher in node-positive tumor samples compared with node-negative samples (P=.02). Tumors with a poor prognostic index and poor histological grade showed a higher level of IL-11. A higher level of IL-11 was linked to poorer survival with Kaplan-Meier survival analysis. IL-11 can be a predictor of poor prognosis in human breast cancer.
- 14 April 2006
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 13 (6) , 802-808
Expression of Interleukin 11 and Its Receptor and Their Prognostic Value in Human Breast Cancer
Recent experimental evidence has shown a potential role of interleukin (IL)-11 and its receptor in breast cancer development and progression. However, there is little clinical information to support this hypothesis. We examined the expression of IL-11 and its receptor in primary breast cancer tissue samples and correlated their level of expression with the clinical outcome. Primary breast cancer samples (n=109) and matched background tissue obtained from patients in the cohort (n=33) were processed for frozen section and RNA extraction. Frozen sections from matched tissues were immunostained with IL-11 and IL-11 receptor antibodies. Staining intensity was analyzed by computer image analysis. RNA was reverse-transcribed and quantified before analysis by quantitative polymerase chain reaction. Results were expressed as the number of transcripts (standardized by beta-actin). The data were compared with the clinical outcome of the disease. The intensity of staining for both IL-11 and the IL-11 receptor was distinctly high in tumor samples (P<.01). The transcript level of IL-11 was significantly higher in node-positive tumor samples compared with node-negative samples (P=.02). Tumors with a poor prognostic index and poor histological grade showed a higher level of IL-11. A higher level of IL-11 was linked to poorer survival with Kaplan-Meier survival analysis. IL-11 can be a predictor of poor prognosis in human breast cancer.
- 1 April 2006
- Published by Elsevier in The Breast
- Vol. 15 (2) , 276-280
The role of tamoxifen in the management of gynaecomastia
- 1 April 2006
- Published by Elsevier in The Breast
- Vol. 15 (2) , 276-280
The role of tamoxifen in the management of gynaecomastia
- 1 February 2006
- Published by Elsevier in The Breast
- Vol. 15 (1) , 123-126
Is mammography overused in male patients?
- 1 February 2006
- Published by Elsevier in The Breast
- Vol. 15 (1) , 123-126
Is mammography overused in male patients?